Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
8.54
-0.01 (-0.12%)
Aug 10, 2026, 12:00 PM EDT - Market open
Phathom Pharmaceuticals Employees
Phathom Pharmaceuticals had 371 employees as of December 31, 2025. The number of employees decreased by 56 or -13.11% compared to the previous year.
Employees
371
Change (1Y)
-56
Growth (1Y)
-13.11%
Revenue / Employee
$645,989
Profits / Employee
-$267,040
Market Cap
678.33M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 371 | -56 | -13.11% |
| Dec 31, 2024 | 427 | -25 | -5.53% |
| Dec 31, 2023 | 452 | 340 | 303.57% |
| Dec 31, 2022 | 112 | 35 | 45.45% |
| Dec 31, 2021 | 77 | 22 | 40.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| REGENXBIO | 371 |
| Allogene Therapeutics | 152 |
| Neurogene | 131 |
| Cybin | 100 |
| AgomAb Therapeutics NV | 62 |
| Zevra Therapeutics | 61 |
| Crescent Biopharma | 55 |
PHAT News
- 10 days ago - Phathom Pharmaceuticals price target lowered to $20 from $22 at Craig-Hallum - TheFly
- 10 days ago - Phathom Pharmaceuticals price target lowered to $21 from $28 at Raymond James - TheFly
- 10 days ago - Phathom Pharmaceuticals price target lowered to $22 from $25 at Guggenheim - TheFly
- 10 days ago - Phathom Pharmaceuticals price target lowered to $22 from $28 at Needham - TheFly
- 11 days ago - Phathom Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts
- 11 days ago - Phathom Pharmaceuticals Earnings release: Q2 2026 - Filings
- 11 days ago - Phathom Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 11 days ago - Phathom Pharmaceuticals Slides: Q2 2026 - Filings